IQVIA Holdings Inc. (QTS.F)

212,50 -0,10 (-0,05%) A partir del 07:55PM CEST. Mercado abierto.

IQVIA Holdings Inc.

2400 Ellis Road
Durham, NC 27703
United States
919 998 2000
https://www.iqvia.com

Sector(es): Healthcare
Sector: Diagnostics & Research
Empleados a tiempo completo: 87.000

Ejecutivos clave

Nombre	Título	Paga	Ejecutado	Año de nacimiento
Mr. Ari Bousbib	CEO & Chairman	6,73M	N/A	1961
Mr. Ronald E. Bruehlman	Executive VP & CFO	2,01M	N/A	1961
Mr. Eric M. Sherbet	Executive VP, General Counsel & Secretary	1,29M	N/A	1964
Mr. W. Richard Staub III	President of Research & Development Solutions	834,64k	3,38M	1963
Mr. Kevin C. Knightly	President of Corporate Strategy & Enterprise Networks	1,17M	2,65M	1961
Ms. Keriann Cherofsky	Senior VP, Corporate Controller & Chief Accounting Officer	N/A	N/A	1985
Mr. Jim Berkshire	Executive Vice President of Global Technology & Operations	N/A	N/A	N/A
Dr. Jeffrey A. Spaeder M.D.	Senior VP, Global Chief Medical & Scientific Officer	N/A	N/A	N/A
Kerri Joseph	SVP of Investment Relation & Treasury	N/A	N/A	N/A
Ms. Trudy Stein	Chief Human Resources Officer & Executive VP	N/A	N/A	N/A

Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en EUR.

Descripción

IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a collaboration with argenx SE. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. The company is headquartered in Durham, North Carolina.

Gobierno corporativo

El ISS Governance QualityScore de IQVIA Holdings Inc., a día 1 de abril de 2024, es 7. Las puntuaciones base son Auditoría: 4; Tablero: 8; Derechos de los accionistas: 7; Compensación: 7.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.